Latest scientific publications

  • Prevalence of Hidradenitis Suppurativa: A Meta-Analysis of Global Hidradenitis Suppurativa Atlas Studies.

  • Auteurs Bouazzi D, Nielsen SM, Hagan PG, Botvid S, Hove LS, Prens EP, Christensen R, Jemec GBE, Knecht-Gurwin K, Szepietowski JC, Anaba EL, Chehad AS, Zobiri S, Serradj A, Bhuiyan MSI, Noor T, Guillem P, Parvizi MM, Saki N, Alpsoy E, Vardar C, Kanni T, Giamarellos-Bourboulis EJ, Frew JW, Al Maharbi WHA, van Huijstee JC, Aarts P, Dewi ST, Febriana SA, Indrastuti N, Suryawati N, Pangastuti M, Adji A, Akhyar G, Nopriyati N, Hazlianda CP, Reyes-Baraona F, Matas C, Saeed H, Moodley A, Binamer Y, Kamil MAA, Jocic I, Mijuskovic Z, Mallawaarachchi K, Gangani C, Tusheva I, Boshkovski VB, Hu D, Geng S, Medianfar CE, Saunte DML, Chandran NS, van der Zee HH, Zouboulis CC, Benhadou F, Villumsen B, Alavi A, Ibekwe PU, Hamzavi IH, Ingram JR, Naik HB, Garg A, Boer J
  • Revue JAMA Dermatol
  • Date de publication 2025-08
Prevalence of Hidradenitis Suppurativa: A Meta-Analysis of Global Hidradenitis Suppurativa Atlas Studies.
  • Identifying and overcoming barriers to referral in advanced heart failure. A scientific statement of the Heart Failure Association (HFA) of the ESC.

  • Auteurs Baudry G, Crespo-Leiro MG, Delmas C, Guidetti F, Bravo MJ, Valente F, Cikes M, Girerd N, Gustafsson F, Savarese G, van Laake LW, Hill L, Skibelund AK, Zuckermann A, Metra M, Damman K
  • Revue Eur J Heart Fail
  • Date de publication 2025-08
Identifying and overcoming barriers to referral in advanced heart failure. A scientific statement of the Heart Failure Association (HFA) of the ESC.
  • The SCARLET trial: a prospective phase II study of somatostatin receptor imaging for potential radiotheranostic application in patients with relapsing and refractory multiple myeloma.

  • Auteurs Delbart W, Karfis I, Vercruyssen M, De Wind R, Meuleman N, Wimana Z, Flamen P, Woff E
  • Revue Eur J Nucl Med Mol Imaging
  • Date de publication 2025-08
The SCARLET trial: a prospective phase II study of somatostatin receptor imaging for potential radiotheranostic application in patients with relapsing and refractory multiple myeloma.
  • Correlation between patient-derived intestinal organoids and clinical responses to CFTR modulators in people with cystic fibrosis homozygous for F508del.

  • Auteurs Rodriguez Mier N, Cuyx S, De Boeck K, Proesmans M, Boon M, Dupont L, Arnauts K, De Wachter E, Van Biervliet S, Lequesne M, Nowé V, Boboli H, Ramalho AS, Vermeulen F
  • Revue J Cyst Fibros
  • Date de publication 2025-08
Correlation between patient-derived intestinal organoids and clinical responses to CFTR modulators in people with cystic fibrosis homozygous for F508del.
  • The effects of lacosamide, pregabalin, and tapentadol on peripheral nerve excitability: A randomized, double-blind, placebo-controlled, crossover, multi-center trial in healthy subjects.

  • Auteurs Nochi Z, Pia H, Bloms-Funke P, Boesl I, Caspani O, Chapman SC, di Pietro G, Fardo F, Genser B, Goetz M, Jiang B, Kostenko AV, Lebrun L, Leone CM, Li T, Möller-Grell N, Mouraux A, Pelz B, Pogatzki-Zahn E, Rong C, Schilder A, Schnetter E, Schubart K, Tracey I, Truini A, Vincent KF, Vollert J, Wanigasekera V, Wittayer M, Treede RD, Tankisi H, Finnerup NB
  • Revue Anesthesiology
  • Date de publication 2025-08
The effects of lacosamide, pregabalin, and tapentadol on peripheral nerve excitability: A randomized, double-blind, placebo-controlled, crossover, multi-center trial in healthy subjects.
Bordet hospital

Jules Bordet Institute

View all of Jules Bordet's scientific publications

Erasme hospital

Erasme Hospital

View all of Erasme's scientific publications

Huderf hospital

Queen Fabiola Children's Hospital

View all scientific publications from the Queen Fabiola Children's Hospital